In a study in the Netherlands of 139 families with BRCA2 mutations, Van Asperen et al (2005) confirmed an excess risk of prostate cancer in first-degree relatives of carriers (OR=2.5; 95% CI 1.6–3.8). Here, BRCA2 is linked to prostate cancer.